- Pin
- 🍕 Bitcoin Pizza Day is Almost Here!
Join the celebration on Gate Post with the hashtag #Bitcoin Pizza Day# to share a $500 prize pool and win exclusive merch!
📅 Event Duration:
May 16, 2025, 8:00 AM – May 23, 2025, 06:00 PM UTC
🎯 How to Participate:
Post on Gate Post with the hashtag #Bitcoin Pizza Day# during the event. Your content can be anything BTC-related — here are some ideas:
🔹 Commemorative:
Look back on the iconic “10,000 BTC for two pizzas” story or share your own memories with BTC.
🔹 Trading Insights:
Discuss BTC trading experiences, market views, or show off your contract gai
- 🎉 Follow to Win! Gate_Activity account is now live!
💰 Follow Gate_Activity and grab your share of $50 Points rewards!
10 Lucky Followers * $5 Points Each
Join:
1️⃣ Follow Gate_Activity 👉 https://www.gate.io/profile/Gate_Activity
2️⃣ Like this post
📅 Deadline: May 17, 10:00 AM (UTC)
Follow now and don't miss the great activities!
- 🚀 Gate.io #Launchpad# for Puffverse (PFVS) is Live!
💎 Start with Just 1 $USDT — the More You Commit, The More #PFVS# You Receive!
Commit Now 👉 https://www.gate.io/launchpad/2300
⏰ Commitment Time: 03:00 AM, May 13th - 12:00 PM, May 16th (UTC)
💰 Total Allocation: 10,000,000 #PFVS#
⏳ Limited-Time Offer — Don’t Miss Out!
Learn More: https://www.gate.io/article/44878
#GateioLaunchpad# #GameeFi#
- 👩 Gate Post User Experience Survey is Now Live! 💻
💙 We sincerely invite you to participate in our survey — your valuable feedback will help us continuously improve and grow!
💰 Complete and successfully submit the questionnaire for a chance to share a $200 points prize pool!
👉 Join Now: https://www.gate.io/questionnaire/6641
⏰ Event Period: May 8, 8:00 AM – May 18, 6:00 PM (UTC)
Innovent Biologics: Positive Results from Phase II Clinical Trial of Innovative Drug ICP-488
Jinshi data news on October 9th, Norcheng Jianhua announced in the evening that the company's innovative drug ICP-488 achieved positive clinical trial results in a phase II randomized, double-blind, placebo-controlled study in patients with moderate to severe plaque psoriasis. The results showed that patients treated with 6mg and 9mg (once daily) of ICP-488 had significant improvement in PASI75 at week 12 compared to patients receiving placebo. In addition, the proportion of patients receiving ICP-488 treatment who achieved PASI90, PASI100, and static Physician Global Assessment (sPGA) 0/1 (i.e., complete or near-complete clearance of skin lesions) was significantly higher than that in the placebo group.